Summer Iris Limited - Net Worth and Insider Trading
Summer Iris Limited Net Worth
The estimated net worth of Summer Iris Limited is at least $535 Million dollars as of 2024-06-22. Summer Iris Limited is the 2101 Beneficial owner of Ocumension Therapeutics and owns about 78,214,230 shares of Ocumension Therapeutics (HKSE:01477) stock worth over $535 Million. Details can be seen in Summer Iris Limited's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Summer Iris Limited has not made any transactions after 2021-12-21 and currently still holds the listed stock(s).
Transaction Summary of Summer Iris Limited
Summer Iris Limited Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Summer Iris Limited owns 1 companies in total, including Ocumension Therapeutics (HKSE:01477) .
Click here to see the complete history of Summer Iris Limited’s form 4 insider trades.
Insider Ownership Summary of Summer Iris Limited
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:01477 | Ocumension Therapeutics | 2021-12-21 | 2101 Beneficial owner |
Summer Iris Limited Latest Holdings Summary
Summer Iris Limited currently owns a total of 1 stock. Summer Iris Limited owns 78,214,230 shares of Ocumension Therapeutics (HKSE:01477) as of December 21, 2021, with a value of $535 Million.
Latest Holdings of Summer Iris Limited
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:01477 | Ocumension Therapeutics | 2021-12-21 | 78,214,230 | 6.84 | 534,985,333 |
Holding Weightings of Summer Iris Limited
Summer Iris Limited Form 4 Trading Tracker
According to the SEC Form 4 filings, Summer Iris Limited has made a total of 1 transactions in Ocumension Therapeutics (HKSE:01477) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Ocumension Therapeutics is the sale of 0 shares on December 21, 2021, which brought Summer Iris Limited around $0.
Insider Trading History of Summer Iris Limited
- 1
Summer Iris Limited Trading Performance
Summer Iris Limited Ownership Network
Summer Iris Limited Owned Company Details
What does Ocumension Therapeutics do?
Who are the key executives at Ocumension Therapeutics?
Summer Iris Limited is the 2101 Beneficial owner of Ocumension Therapeutics. Other key executives at Ocumension Therapeutics include 2201 Interest of corporation controlled by you Temasek Holdings (private) Limited , 2101 Beneficial owner Liu Ye , and 2201 Interest of corporation controlled by you Boyu Capital Group Holdings Ltd .
Ocumension Therapeutics (HKSE:01477) Insider Trades Summary
Over the past 18 months, Summer Iris Limited made no insider transaction in Ocumension Therapeutics (HKSE:01477). Other recent insider transactions involving Ocumension Therapeutics (HKSE:01477) include a net sale of 500 shares made by Liu Ye , a net sale of 3,800,000 shares made by Temasek Holdings (private) Limited , and a net sale of 427,000 shares made by The Capital Group Companies, Inc. .
In summary, during the past 3 months, insiders sold 1,500,000 shares of Ocumension Therapeutics (HKSE:01477) in total and bought 0 shares, with a net sale of 1,500,000 shares. During the past 18 months, 4,227,500 shares of Ocumension Therapeutics (HKSE:01477) were sold and 150,000 shares were bought by its insiders, resulting in a net sale of 4,077,500 shares.
Ocumension Therapeutics (HKSE:01477)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ocumension Therapeutics Insider Transactions
Summer Iris Limited Mailing Address
Above is the net worth, insider trading, and ownership report for Summer Iris Limited. Currently GuruFocus does not have mailing address information for Summer Iris Limited.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
